Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: To evaluate the effect of intraocular lens (IOL) implantation on the development of secondary glaucoma after cataract surgery in pediatric patients.
Design: Retrospective case series study.
Methods: This study reviewed the medical records of children under 16 years of age who had undergone cataract surgery from 1996 to 2016 for congenital or developmental cataract. In every child an IOL was implanted in the primary surgery. Data collected included demographic information, age at cataract diagnosis and at surgery, surgical procedure, and postoperative follow-up of refraction, cup-to-disc ratio (C/D), intraocular pressure (IOP), and associated systemic and ocular anomalies. Patients with risk factors for glaucoma were excluded from the study.
Results: Of the 255 children below age 16 years who underwent cataract extraction surgery with primary IOL implantation, 73 (124 eyes) met the inclusion criteria. Follow-up ranged from 4 to 18 years. Only 1 patient (0.8% of the 124 eyes) developed glaucoma in 1 of his 2 operated eyes; the surgeries were performed at 10 months, 1 week apart, and glaucoma was diagnosed 4 months later. One patient had suspected glaucoma in both eyes (incidence of 1.6%). Both these children were of Bedouin origin.
Conclusion: IOL implantation, by itself, is not a risk factor for development of secondary glaucoma after cataract surgery in a population below 16 years of age.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jcjo.2019.01.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gonioscopy unveils completely unemulsified silicone oil anterior chamber filling with secondary open-angle glaucoma.
Retina
June 2025
Ophthalmology Department 5, National Hospital 15-20, Paris, France.
Out-Of-The-Bag Intraocular Lens Dislocation in Dead Bag Syndrome and Its Association With Eye Rubbing.
Clin Exp Ophthalmol
September 2025
Department of Neurosurgery, National Neuroscience Institute, Singapore, Singapore.
Background: To describe clinical features, risk factors and outcomes of out-of-the-bag (OTB) intraocular lens (IOL) dislocation in dead bag syndrome (DBS).
Methods: Retrospective review of a single-surgeon series of eyes with IOLs that developed OTB IOL dislocation, managed at Singapore National Eye Centre (January 2014-December 2021), with a minimum of 6 months of follow-up. Eyes with OTB IOL dislocation following secondary IOL implantation and intraoperative capsule complications were excluded.
Optimization of ciliary body cyclophotocoagulation settings: a randomized and controlled pilot study.
Can J Ophthalmol
September 2025
Département d'Ophtalmologie et d'Ophtalmologie et d'Oto-Rhino-Laryngologie-Chirurgie Cervico-Faciale, Faculté de Médecine, Université Laval, QC, Canada; Centre Universitaire d'Ophtalmologie, Hôpital du Saint-Sacrement, Centre Hospitalier Universitaire de Québec-Université Laval, QC, Canada.
Objective: To compare the efficacy of different settings in continuous-wave transscleral cyclophotocoagulation (CW-TSCPC).
Design: Prospective, randomized, triple-blind clinical trial in a single tertiary center.
Participants: Adult glaucoma patients who need continuous wave-transscleral cyclophotocoagulation to control intraocular pressure (IOP) or prevent or treat ocular pain/discomfort secondary to increased IOP.
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma:5-Year Safety Results from a Randomized, Multicenter Study.
Ophthalmol Glaucoma
September 2025
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, England; Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, New South Wales, Australia.
Purpose: To compare the long-term safety of MicroShunt implantation with trabeculectomy in eyes with primary open-angle glaucoma (POAG).
Methods: This was a 3-year observational extension of a 2-year prospective randomized trial comparing clinical outcomes of MicroShunt implantation with trabeculectomy, both augmented with mitomycin C. Adverse events (AEs), intraocular pressure (IOP), and IOP-lowering medication use were recorded 36, 48, and 60 months after initial randomization.
Prevalence, Incidence, and Treatment Characteristics of Primary Open-Angle Glaucoma Among Medicare Fee-for-Service Beneficiaries.
Clin Ophthalmol
August 2025
Global Health Economics and Outcomes Research, Bausch + Lomb U.S., Bridgewater, NJ, USA.
Purpose: This study aimed to describe Medicare FFS beneficiaries with prevalent and incident POAG, and to determine their demographic characteristics. Secondary objectives included describing POAG prescription rates, prescribers of POAG therapy, and dry eye disease rates among POAG prevalent beneficiaries.
Patients And Methods: The study was a retrospective cohort analysis using de-identified Medicare FFS medical and pharmacy claims and enrollment data (Parts A/B/D) spanning from January 1, 2016, to December 31, 2021.